XML 34 R22.htm IDEA: XBRL DOCUMENT
v3.23.1

COVID-19 Developments | 3 Months Ended
--- | ---
Mar. 31, 2023
C O V I D19 Developments [Abstract] |
COVID-19 Developments | Note 15 — COVID-19 Developments In December 2019, COVID-19 surfaced and in March 2020, the World Health Organization declared a pandemic related to the rapid spread of COVID-19 around the world. The impact of the COVID-19 outbreak on the businesses and the economy in the U.S. and the rest of the world is, and is expected to continue to be, uncertain and may continue to be significant as COVID-19 variant strains emerge. The Company’s revenues have been adversely impacted, and the Company experienced a substantial slowdown in sales beginning March 20, 2020 in global geographies characterized as “hot spots” for the COVID-19 virus, including parts of Europe, North America, Asia, the Middle East and India. In certain of these markets, sales have paused as elective surgeries are discouraged to support COVID-19 related needs. While COVID-19 restrictions have since eased globally during 2022, a resurgence of the COVID-19 pandemic in global geographies, depending upon its duration and severity, could material adversely impact the global economy and the Company's industry, operations and financial condition and performance. The Company continues to monitor the commercial and operational impact of new variants of COVID-19 in its markets.

X
- Definition COVID-19 developments. + References No definition available. + Details
Name: | staa_COVID19DevelopmentsAbstract
Namespace Prefix: | staa_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition COVID- 19 developments. + References No definition available. + Details
Name: | staa_Covid19DevelopmentsTextBlock
Namespace Prefix: | staa_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration